New York, NY, United States of America

Geyi Liu

This inventor holds 1 USPTO granted patent. Top assignee: Regents of the University of Minnesota. Active years: 2012.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Geyi Liu - Innovator in Transposon Technology

Introduction

Geyi Liu is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of genetic engineering, particularly through his work on transposons and transposases. His innovative approach has led to advancements in gene transfer systems, which are crucial for various applications in biotechnology.

Latest Patents

Geyi Liu holds a patent for a "Transposon system and methods of use." This invention focuses on improved transposons and transposases, providing methods for their use and compositions that include these elements. His work in this area has the potential to enhance gene transfer techniques, making them more efficient and effective.

Career Highlights

Geyi Liu is affiliated with the Regents of the University of Minnesota, where he continues to engage in groundbreaking research. His career is marked by a commitment to advancing the understanding and application of genetic technologies. With a total of 1 patent, he has established himself as a key figure in his field.

Collaborations

Throughout his career, Geyi Liu has collaborated with notable colleagues, including Zongbin Cui and Perry B Hackett. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Geyi Liu's contributions to transposon technology exemplify the impact of innovative thinking in the field of genetics. His work not only advances scientific knowledge but also paves the way for future developments in biotechnology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…